Atom | Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3

Due Dates: October 16, 2025 (estimated application due date; forecasted)

Funding Amounts: Award size and duration not yet specified; UG3/UH3 cooperative agreement mechanism; details to be announced in the full NOFO.

Summary: NIDA will support research on the discovery and development of interventions to prevent and treat substance use disorders and overdose, spanning preclinical to clinical studies.

Key Information: This is a forecasted opportunity; applications are not yet being accepted. Notice is provided to allow time for collaboration and project planning.

Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Sign in to see full grant listing